ID

13534

Beskrivning

Microvascular and Antiinflammatory Effects of Rivaroxaban Compared to Aspirin in Type-2 Diabetic Patients With Cardiovascular Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02164578

Länk

https://clinicaltrials.gov/show/NCT02164578

Nyckelord

  1. 2016-02-14 2016-02-14 -
Uppladdad den

14 februari 2016

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Type 2 Diabetic Patients NCT02164578

Eligibility Type 2 Diabetic Patients NCT02164578

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
Type 2 diabetes duration between 2 and 20 years
Beskrivning

Type 2 diabetes

Datatyp

boolean

Alias
UMLS CUI [1]
C0011860
Documented atherosclerotic cvd:
Beskrivning

Cvd

Datatyp

boolean

Alias
UMLS CUI [1]
C0007222
Major cardiovascular event in medical history
Beskrivning

Cardiovascular event

Datatyp

boolean

Alias
UMLS CUI [1]
C1320716
Coronary angiography showing a coronary artery stenosis of > 50 % or
Beskrivning

Coronary Stenosis

Datatyp

boolean

Alias
UMLS CUI [1]
C0242231
Carotid ultrasound showing an imt > 1 mm and plaque of carotid artery
Beskrivning

Carotid Artery Plaque

Datatyp

boolean

Alias
UMLS CUI [1]
C0751633
Left ventricular hypertrophy
Beskrivning

Left ventricular hypertrophy

Datatyp

boolean

Alias
UMLS CUI [1]
C0149721
Macroalbuminuria in the absence of other renal diseases
Beskrivning

Macroalbuminuria

Datatyp

boolean

Alias
UMLS CUI [1]
C1654921
Increased hscrp (> 2 mg/l but < 10 mg/l) and/or increased pai 1 (> 15 ng/ml)
Beskrivning

High-sensitivity C-reactive protein increased (hscrp)

Datatyp

boolean

Alias
UMLS CUI [1]
C1963867
Stable treatment with statins (if tolerated)
Beskrivning

Statin therapy

Datatyp

boolean

Alias
UMLS CUI [1]
C1314135
Age 40 - 75 years
Beskrivning

Age 40 - 75 years

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
CV event with need for oral anticoagulation or dual platelet inhibitor therapy or acute coronary syndrome < 12 month before study entry
Beskrivning

Cardiovascular event

Datatyp

boolean

Alias
UMLS CUI [1]
C1320716
Sustained uncontrolled hypertension: systolic bp > 180 mmhg or diastolic bp > 100 mmhg
Beskrivning

Uncontrolled hypertension

Datatyp

boolean

Alias
UMLS CUI [1]
C1868885
Hypersensitivity to the active substance
Beskrivning

Hypersensitivity

Datatyp

boolean

Alias
UMLS CUI [1]
C0020517
Active clinically significant bleeding
Beskrivning

Bleeding

Datatyp

boolean

Alias
UMLS CUI [1]
C0741554
Significant risks for major bleeding
Beskrivning

Bleeding Risk

Datatyp

boolean

Alias
UMLS CUI [1]
C3251812
Concomitant treatment of acs with antiplatelet therapy in patients with a prior stroke or a transient ischaemic attack (tia)
Beskrivning

Antiplatelet therapy

Datatyp

boolean

Alias
UMLS CUI [1]
C1096021
Hepatic disease associated with coagulopathy and clinically relevant bleeding risk
Beskrivning

Hepatic disease

Datatyp

boolean

Chronic renal failure with egfr < 15 ml/min (mdrd formula)
Beskrivning

Chronic renal failure

Datatyp

boolean

Alias
UMLS CUI [1]
C0022661
Pregnant or breast-feeding woman and woman without adequate method of contraception.
Beskrivning

Pregnant or breast-feeding

Datatyp

boolean

Alias
UMLS CUI [1]
C0549206
UMLS CUI [2]
C0006147

Similar models

Eligibility Type 2 Diabetic Patients NCT02164578

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Type 2 diabetes
Item
Type 2 diabetes duration between 2 and 20 years
boolean
C0011860 (UMLS CUI [1])
Cvd
Item
Documented atherosclerotic cvd:
boolean
C0007222 (UMLS CUI [1])
Cardiovascular event
Item
Major cardiovascular event in medical history
boolean
C1320716 (UMLS CUI [1])
Coronary Stenosis
Item
Coronary angiography showing a coronary artery stenosis of > 50 % or
boolean
C0242231 (UMLS CUI [1])
Carotid Artery Plaque
Item
Carotid ultrasound showing an imt > 1 mm and plaque of carotid artery
boolean
C0751633 (UMLS CUI [1])
Left ventricular hypertrophy
Item
Left ventricular hypertrophy
boolean
C0149721 (UMLS CUI [1])
Macroalbuminuria
Item
Macroalbuminuria in the absence of other renal diseases
boolean
C1654921 (UMLS CUI [1])
High-sensitivity C-reactive protein increased (hscrp)
Item
Increased hscrp (> 2 mg/l but < 10 mg/l) and/or increased pai 1 (> 15 ng/ml)
boolean
C1963867 (UMLS CUI [1])
Statin therapy
Item
Stable treatment with statins (if tolerated)
boolean
C1314135 (UMLS CUI [1])
Age 40 - 75 years
Item
Age 40 - 75 years
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Cardiovascular event
Item
CV event with need for oral anticoagulation or dual platelet inhibitor therapy or acute coronary syndrome < 12 month before study entry
boolean
C1320716 (UMLS CUI [1])
Uncontrolled hypertension
Item
Sustained uncontrolled hypertension: systolic bp > 180 mmhg or diastolic bp > 100 mmhg
boolean
C1868885 (UMLS CUI [1])
Hypersensitivity
Item
Hypersensitivity to the active substance
boolean
C0020517 (UMLS CUI [1])
Bleeding
Item
Active clinically significant bleeding
boolean
C0741554 (UMLS CUI [1])
Bleeding Risk
Item
Significant risks for major bleeding
boolean
C3251812 (UMLS CUI [1])
Antiplatelet therapy
Item
Concomitant treatment of acs with antiplatelet therapy in patients with a prior stroke or a transient ischaemic attack (tia)
boolean
C1096021 (UMLS CUI [1])
Hepatic disease
Item
Hepatic disease associated with coagulopathy and clinically relevant bleeding risk
boolean
Chronic renal failure
Item
Chronic renal failure with egfr < 15 ml/min (mdrd formula)
boolean
C0022661 (UMLS CUI [1])
Pregnant or breast-feeding
Item
Pregnant or breast-feeding woman and woman without adequate method of contraception.
boolean
C0549206 (UMLS CUI [1])
C0006147 (UMLS CUI [2])

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial